Pharma Journalist -

MilliporeSigma launched its new BioContinuum Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and…
Read More...

Eli Lilly and Company and NextCure announced a multi-year collaboration focused on the discovery and development of immuno-oncology therapies. The collaboration seeks to discover novel…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LORBRENA® (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase…
Read More...

NuMedii announced the formation of a research collaboration with Johns Hopkins School of Medicine with the goal of discovering new targets and therapeutic options for pancreatitis. The…
Read More...

Understanding your audience through digital channels is key in today's healthcare world, as patients are using devices and moving more onto online communications to contact and find…
Read More...

Denali Therapeutics Inc. announced that it will collaborate with Sanofi on the development of multiple RIPK1 inhibitor molecules with the potential to treat a range of neurological and…
Read More...

Pharmaceutical Product Development, LLC (PPD) has enhanced its global product development services, adding significant expertise in multiple therapeutic areas, including neuroscience,…
Read More...

PMI BioPharma Solutions, a specialty CDMO providing Contract Research, Drug Discovery, Development and Manufacturing Services officially formed in January of 2018, announced that David…
Read More...

Gilead Sciences and Tango Therapeutics announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted immuno-oncology treatments for…
Read More...

Novo Nordisk announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights to Macrilen(TM) (macimorelin), the first and only FDA-approved oral…
Read More...